In a bid to reduce the time and cost associated with developing promising new medicines, University of Toronto scientists have successfully tested the use of artificial intelligence to guide the design of long-acting injectable drug formulations. The study, published this week in Nature Communication, was led by Professor Christine Allen in the Leslie Dan Faculty of Pharmacy and Alán… Learn More
[…]
